Our Science & Technology
At Cardiol, we think medicine should work better. To improve the quality of life for people living with heart failure, we are developing innovative nanotherapeutics that target anti-inflammatory drugs to inflamed tissue in the heart.
Our proprietary nanotherapeutics are designed to increase the compatibility of drugs with the aqueous blood circulation, improve pharmacokinetics, and facilitate drug accumulation in the failing heart.
We believe this approach holds the answer to improving the standard of care for millions of heart failure patients and reducing the significant economic burden this disease has on the healthcare system.